Grant
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
This federal SBIR grant opportunity supports US small business concerns in conducting feasibility studies through late-stage research and development to bring scientific innovations to the commercial marketplace.
See your fitKey facts
- Organiser
- National Institutes of Health
- Deadline
- April 5, 2027
- Opens
- May 28, 2026
- Amount
- Grant
- Open to
- United States
- Sectors
- Any sector
4 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Who can apply to NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)?
Eligible locations: United States. The company must be incorporated in United States. Other requirements: Non-domestic (non-U.S.) Entities are not eligible to apply.
When is the NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline?
The NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline is April 5, 2027. Applications opened on May 28, 2026.
Other programs in this category
- NLnet Foundation Open Call (deadline January 3, 2027)
- NSF SBIR/STTR Phase I, Phase II, Fast-Track Programs (America's Seed Fund)
- NYSTAR Innovation Matching Grants Program
- Phasebridge Deep Tech Passport
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
- UK Defence Innovation: Rapid Detection of Toxic Gases Phase 2
Programs like this in the United States
Verified on September 28, 2026 against the official page.